Lineage Cell Therapeutics, Inc. Public Utilities, Property, Plant and Equipment, Construction Work in Progress
Lineage Cell Therapeutics, Inc. (LCTX) had Public Utilities, Property, Plant and Equipment, Construction Work in Progress of $8.92 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes
us-gaap:PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress · last filed 2019-05-09
- 2019-03-31: Public Utilities, Property, Plant and Equipment, Construction Work in Progress $8.92M.
- 2018-12-31: Public Utilities, Property, Plant and Equipment, Construction Work in Progress $5.83M.
- 2018-09-30: Public Utilities, Property, Plant and Equipment, Construction Work in Progress $5.12M.
- 2017-12-31: Public Utilities, Property, Plant and Equipment, Construction Work in Progress $5.53M.
| Period end | Public Utilities, Property, Plant and Equipment, Construction Work in Progress |
|---|---|
| 2019-03-31 | $8.92M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.83M 10-Q · filed 2019-05-09 |
| 2018-09-30 | $5.12M 10-Q · filed 2018-11-08 |
| 2017-12-31 | $5.53M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |